SCHEMBL2615985

SCHEMBL2615985

Cc1cc(-c2cccc(Cl)c2)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.50
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
MAP4K4 O95819 1/20 0.49
DYRK1A Q13627 1/20 0.49
ESR2 Q92731 1/20 0.49
GRM2 Q14416 2/20 0.48
PIM1 P11309 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
TDO2 P48775 2/20 0.45
NOTUM Q6P988 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1896511 0.81 DYRK1A (0.65) MAP4K4DYRK1ACYP3A4CYP2D6PSEN1
SCHEMBL30308690 0.81 DYRK1A (0.65) MAP4K4DYRK1ACYP3A4CYP2D6PSEN1
SCHEMBL6747565 0.81 MAPK14 (0.51) CNR2GRM2PIM1TDO2NOTUM
SCHEMBL9195160 0.81 GAA (0.43) RAB9ANPC1GRM2MAPT
SCHEMBL2615984 0.80 DYRK1A (0.61) RAB9ASMN1; SMN2NPC1MAP4K4DYRK1A
SCHEMBL19537427 0.80 ESR2 (0.52) RAB9ASMN1; SMN2NPC1ESR2GRM2
SCHEMBL11992043 0.80 UHRF1 (0.58) RAB9AMAP4K4DYRK1APSEN1PSEN2
SCHEMBL8383748 0.80 DYRK1A (0.56) MAP4K4DYRK1APSEN1PSEN2APH1B
SCHEMBL5257164 0.80 GRM2 (0.43) DYRK1AGRM2PIM1TDO2
SCHEMBL5255541 0.80 GRM2 (0.46) RAB9ASMN1; SMN2NPC1GRM2TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785445-B2 7-phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2014-07-22 US disclosed
US-20120101103-A1 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101103-A1 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES PTGDR2, PTGDR, HRH2 CNR2 360/4885RAB9A 1293/4885SMN1; SMN2 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.